CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNYSE:CFN
CUSIP14170T10
Phone+1-800-6848880
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins16.18%
Return on Equity12.80%
Return on Assets7.62%
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$12,240.00
CareFusion (NYSE:CFN) Frequently Asked Questions
What is CareFusion's stock symbol?
CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."
How were CareFusion's earnings last quarter?
CareFusion Co. (NYSE:CFN) posted its quarterly earnings data on Thursday, February, 5th. The healthcare company reported $0.99 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.79 by $0.20. The healthcare company earned $1.07 billion during the quarter, compared to analysts' expectations of $1.01 billion. CareFusion had a return on equity of 12.80% and a net margin of 16.18%. CareFusion's revenue was up 15.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.54 EPS. View CareFusion's Earnings History.
What is the consensus analysts' recommendation for CareFusion?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CareFusion in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Has CareFusion been receiving favorable news coverage?
News stories about CFN stock have trended somewhat positive this week, Accern Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. CareFusion earned a news impact score of 0.02 on Accern's scale. They also gave press coverage about the healthcare company an impact score of 45.38 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
What is CareFusion's stock price today?
One share of CFN stock can currently be purchased for approximately $59.94.
How big of a company is CareFusion?
CareFusion has a market capitalization of $12.24 billion.
How can I contact CareFusion?
CareFusion's mailing address is 3750 Torrey View Ct, SAN DIEGO, CA 92130-2622, United States. The healthcare company can be reached via phone at +1-800-6848880.
MarketBeat Community Rating for CareFusion (NYSE CFN)
MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe CFN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CFN will underperform the S&P 500 over the long term. You may vote once every thirty days.
